Relay Technology Management (Relay TM) has introduced Business Development Live (BD Live!), a new unified, real-time data visualization, comparative asset analysis and tracking platform for the life sciences industry.
BD Live! enables comparative asset analysis via an industry-first Relative Valuation Index (RVI) which accounts for the stage of asset development and factors in competitive environment, scientific evidence, investments, proof of mechanism, research momentum, FDA and transactional trends.
The new real-time business intelligence solution aggregates and visualizes data from a comprehensive list of life science sources, including 27 million data points and a combination of scientific and business literature, technology transfer data, and clinical trial data.
BD Live! offers real-time, analytical and customizable dashboards on drug profiles and targets, researchers and institutions to rapidly compare related categories, such as emerging drug targets and approaches in a particular therapeutic area.
Relay TM co-founder and managing director David Greenwald said, "BD Live! provides access to a comprehensive information repository on biopharma assets and other relevant entities and utilizes cutting-edge data visualization technologies to create interactive dashboards that dramatically improve the user experience."
